Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences Net Income (Quarterly) : -13.20M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.20M |
| March 31, 2026 | -21.32M |
| Date | Value |
|---|---|
| June 30, 2025 | -7.023M |
| March 31, 2025 | -7.659M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| 10X Genomics, Inc. | -17.93M |
| Personalis, Inc. | -31.68M |
| Adaptive Biotechnologies Corp. | -39.94M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 121.36M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 29.43M |
| Total Expenses (Quarterly) | 42.63M |
| EPS Diluted (Quarterly) | -0.1902 |
| Enterprise Value | 2.186B |
| Gross Profit Margin (Quarterly) | 60.21% |
| Profit Margin (Quarterly) | -44.85% |
| Earnings Yield | -2.07% |
| Normalized Earnings Yield | -1.772 |